Monash IVF Group Ltd
ASX:MVF

Watchlist Manager
Monash IVF Group Ltd Logo
Monash IVF Group Ltd
ASX:MVF
Watchlist
Price: 0.735 AUD -10.37% Market Closed
Market Cap: 286.4m AUD

Intrinsic Value

The intrinsic value of one MVF stock under the Base Case scenario is 1.348 AUD. Compared to the current market price of 0.735 AUD, Monash IVF Group Ltd is Undervalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MVF Intrinsic Value
1.348 AUD
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Monash IVF Group Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about MVF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MVF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Monash IVF Group Ltd.

Explain Valuation
Compare MVF to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Regulatory shifts or reduced government support for fertility services could significantly lower patient volumes, pressuring Monash IVF Group’s revenue and margins in its core Australian market.

Increased competition from both established IVF providers and emerging low-cost clinics may erode Monash IVF’s market share, forcing price concessions and reducing profitability.

A growing reliance on specialized fertility medical professionals, coupled with industry-wide shortages, could escalate staffing expenses or impede expansion if key medical talent is difficult to retain.

Bull Theses

Monash IVF’s longstanding brand reputation and strong clinical success rates empower it to attract a steady stream of patients and top fertility specialists, reinforcing its leadership position.

Shifting demographics, including delayed family planning and rising infertility rates, support continued growth in IVF demand, which Monash IVF Group can capture both domestically and in Southeast Asia.

The company’s investment in emerging reproductive technologies and genetic screening capabilities enhances treatment outcomes, potentially boosting margins by drawing higher-end clientele and strengthening patient loyalty.

Show More Less
How do you feel about MVF?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Monash IVF Group Ltd

Current Assets 41.7m
Cash & Short-Term Investments 9.4m
Receivables 23.3m
Other Current Assets 9m
Non-Current Assets 450.9m
Long-Term Investments 1.3m
PP&E 146m
Intangibles 297.2m
Other Non-Current Assets 6.3m
Current Liabilities 61.4m
Accounts Payable 20.5m
Accrued Liabilities 14.6m
Other Current Liabilities 26.3m
Non-Current Liabilities 184.9m
Long-Term Debt 170.3m
Other Non-Current Liabilities 14.6m
Efficiency

Free Cash Flow Analysis
Monash IVF Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Monash IVF Group Ltd

Revenue
271.9m AUD
Cost of Revenue
-29.5m AUD
Gross Profit
242.5m AUD
Operating Expenses
-198.3m AUD
Operating Income
44.2m AUD
Other Expenses
-19.2m AUD
Net Income
25m AUD
Fundamental Scores

MVF Profitability Score
Profitability Due Diligence

Monash IVF Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
ROE is Increasing
51/100
Profitability
Score

Monash IVF Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

MVF Solvency Score
Solvency Due Diligence

Monash IVF Group Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
39/100
Solvency
Score

Monash IVF Group Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MVF Price Targets Summary
Monash IVF Group Ltd

Wall Street analysts forecast MVF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MVF is 0.821 AUD with a low forecast of 0.657 AUD and a high forecast of 0.998 AUD.

Lowest
Price Target
0.657 AUD
11% Downside
Average
Price Target
0.821 AUD
12% Upside
Highest
Price Target
0.998 AUD
36% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MVF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MVF stock?

The intrinsic value of one MVF stock under the Base Case scenario is 1.348 AUD.

Is MVF stock undervalued or overvalued?

Compared to the current market price of 0.735 AUD, Monash IVF Group Ltd is Undervalued by 45%.

Back to Top